Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Ticagrelor Antiplatelet Therapy to Reduce Graft Events and Thrombosis (TARGET)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02053909
Recruitment Status : Recruiting
First Posted : February 4, 2014
Last Update Posted : July 9, 2019
Sponsor:
Collaborators:
AstraZeneca
Ottawa Heart Institute Research Corporation
Information provided by (Responsible Party):
Dr. Alexander Kulik, Boca Raton Regional Hospital

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : August 2022
Estimated Study Completion Date : August 2023